EU Panel Endorses First-of-Its-Kind Lung Cancer Drug EU Panel Endorses First-of-Its-Kind Lung Cancer Drug
Sotorasib is the first drug to successfully target KRAS mutations in non-small cell lung cancer.International Approvals
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Radiology